Sensorion Receives Positive Recommendation for Audiogene Trial of SENS-501

Sensorion Receives Positive Recommendation for Audiogene Trial of SENS-501 Sensorion, a clinical-stage biotechnology company focused on developing novel therapies to treat and prevent hearing loss, has announced a positive recommendation from the Data Monitoring Committee (DMC) for its Phase 1/2…










